Pharma Journalist - Page 692 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

DermTech exhibited PLA against High Risk DNA Mutations

Photocure declares that FDA approved Blue Light Cystoscopy with Cysview

Lead Cell Medica Financing appointed Kevin S. Boyle as CFO

Teva declares commercial availability of QVAR RediHaler Inhalation Aerosol

Shawn M. Cross appointed CEO of GT Biopharma

FDA commissioner Scott Gottlieb issues statement on influenza vaccine

Arrowhead sought MEDSAFE for ARO-HBV study

Aravive Biologics begins Phase 1 Clinical Trial of AVB-S6-500

Arrowhead Pharmaceuticals seeks Orphan Drug Designation for ARO-AAT